Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome
Cells · 2023
DOI: 10.3390/cells12141860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Tim M G MacKenzie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Department, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Proteome, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sarafan ChEM-H Institute, Innovative Medicines Accelerator at Stanford University.
Abstract (Originalsprache)
A phenotypic hallmark of cancer is aberrant transcriptional regulation. Transcriptional regulation is controlled by a complicated array of molecular factors, including the presence of transcription factors, the deposition of histone post-translational modifications, and long-range DNA interactions. Determining the molecular identity and function of these various factors is necessary to understand specific aspects of cancer biology and reveal potential therapeutic targets. Regulation of the genome by specific factors is typically studied using chromatin immunoprecipitation followed by sequencing (ChIP-Seq) that identifies genome-wide binding interactions through the use of factor-specific antibodies. A long-standing goal in many laboratories has been the development of a ‘reverse-ChIP’ approach to identify unknown binding partners at loci of interest. A variety of strategies have been employed to enable the selective biochemical purification of sequence-defined chromatin regions, including single-copy loci, and the subsequent analytical detection of associated proteins. This review covers mass spectrometry techniques that enable quantitative proteomics before providing a survey of approaches toward the development of strategies for the purification of sequence-specific chromatin as a ‘reverse-ChIP’ technique. A fully realized reverse-ChIP technique holds great potential for identifying cancer-specific targets and the development of personalized therapeutic regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Department, Stanford University, Stanford, CA 94305, USA.
- Sarafan ChEM-H/IMA Postbaccalaureate Fellow in Target Discovery, Stanford University, Stanford, CA 94305, USA.
ORCID-Profile: Tim M G MacKenzie, Michael P Snyder
Förderung
- Sarafan ChEM-H Institute
- Innovative Medicines Accelerator at Stanford University
Zitieren
APA
MacKenzie, T. M. G., Cisneros, R., Maynard, R. D., & Snyder, M. P. (2023). Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome. Cells. https://doi.org/10.3390/cells12141860
Vancouver
MacKenzie TMG, Cisneros R, Maynard RD, Snyder MP. Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome. Cells. 2023. doi:10.3390/cells12141860
BibTeX
@article{MacKenzie2023,
author = {MacKenzie, Tim M G and Cisneros, Rocío and Maynard, Rajan D and Snyder, Michael P},
title = {Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12141860}
}
EUVIMED